Clariane SE Stock: price and insider trades · France

Clariane SE, classified in the Healthcare & Pharma sector, is a listed company based in Paris, Belgium, founded in 2023. Its insiders report their share dealings to AMF. Over the twelve months to 18 October 2026, the company's managers filed 26 filings, from 3 insiders.

Not one open-market sale was filed. On the buying side, 2 insiders reported 25 purchases totalling €2.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 board members. HLD Europe SCA filed the largest purchase, €936k, on 30 April 2026, which represents 0.064% of the company's market value.

With 26 filings in twelve months, the company is more active than the median of 6 filings across the 316 companies we follow on the same exchange. The full history, which starts in 2021, counts 44 purchases against 2 sales.

Within a 30-day window, 1 purchase overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 29 September 2026, 18 days ago. Between a trade and the moment it shows up on AMF, the median delay is 6 days. The legal deadline for notifying a trade is three business days (MAR article 19).

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from AMF. Past trades are no guide to future returns.